-
Presenter Perspectives: Diet as Both Cause and Intervention for Cancer
Marcus D. Goncalves, MD, PhD, shares details about this presentation, which begins Tuesday, June 29, at 9:30 a.m. ET.
-
Presenter Perspectives: Disparity of Risk for Impaired Awareness of Hypoglycemia and Severe Hypoglycemia—Exploring the Human Situation
Amir Moheet, MBBS, shares details about this presentation, which begins Friday, June 25, at 1:15 p.m. ET.
-
Researchers will provide new data from SCORED and SOLOIST trials
A combined SGLT1/SGLT2 inhibitor may be the next addition to the armamentarium of drugs for patients with diabetes. Deepak Bhatt, MD, MPH, will explain why and take a comprehensive look at data from recent clinical trials of sotagliflozin.
-
Investigators to share first cardiovascular outcomes results from AMPLITUDE-O
Hertzel C. Gerstein, MD, MSc, FRCPC, will offer insight into the use of an exendin-based GLP-1 receptor agonist in people with type 2 diabetes and high cardiovascular risk.
-
ADA and EASD draft first consensus report on type 1 diabetes in adults
Richard I.G. Holt, PhD, FRCP, and Anne L. Peters, MD, and their writing team will summarize the key topics addressed by this trans-Atlantic collaboration.
-
Diabetes self-management training goes virtual for VA and Defense Department
Veterans and active-duty military personnel with diabetes can now receive self-management education in a simulated environment.
-
Experts to review latest findings on GIP signaling
Makoto Fukuda, PhD, and Tune H. Pers, PhD, will discuss GIP signaling in the brain and its effects on food intake and energy balance at this year’s ADA Diabetes Symposium.
-
Session will celebrate life-changing century of insulin discovery, advances
In 1921, the discovery of insulin transformed type 1 diabetes from a death sentence. Peter Arvan, MD, PhD, and Michael A. Weiss, MD, PhD, MBA, will explore the ramifications of this critical inflection point in medicine.
-
Mental health is key to comprehensive care at all ages
Maisa N. Feghali, MD, Randi Streisand, PhD, CDCES, and Jessica Pierce, PhD, will outline how the strategies providers use to promote positive mental health for their patients living with diabetes must evolve as their patients mature.
-
Pandemic-related changes to diabetes care during pregnancy may be here to stay
David McIntyre, MD, FRACP, and Noelia M. Zork, MD, will discuss the perfect storm created by the confluence of COVID-19, diabetes, and pregnancy—from new approaches to the diagnosis and management of diabetes in pregnancy to an expansion of telemedicine.